VIVUS, Auxilium get sNDA approval for Stendra
VIVUS Inc. and Auxilium Pharmaceuticals Inc. have gained Food and Drug Administration approval for a supplemental new drug application (sNDA) for Stendra, a treatment for erectile dysfunction (ED).
VIVUS Inc. and Auxilium Pharmaceuticals Inc. have gained Food and Drug Administration approval for a supplemental new drug application (sNDA) for Stendra, a treatment for erectile dysfunction (ED).
The Senate Committee on Health, Education, Labor and Pensions has approved a bill that aims to clear a regulatory backlog impeding U.S. consumer access to new sunscreen products. The committee on Wednesday passed the Sunscreen Innovation Act (S. 2141), introduced in the Senate by Sens.
Out of Africa has added to its skin care lineup with the launch of Whipped & Creamy Shea Body Butters.
Surescripts is expanding its electronic prior authorization (ePA) service for e-prescribing with four national pharmacy benefit managers (PBMs), including CVS/caremark and Express Scripts, and six health technology vendors.
Zarbee’s Naturals, the maker of a natural cough syrup for children, has expanded its wellness offerings with a new line of immune support products for every member of the family, from infants as young as 2 months to toddlers, tweens and their parents. Zarbee’s said Tuesday that each of the four
AstraZeneca has partnered with actor James Van Der Beek on a campaign to stress the importance of getting an annual flu vaccination and to address common myths about influenza. Actor James Van Der Beek receives a FluMist Quadrivalent nasal spray flu vaccine.
Pharmavite LLC has appointed Etienne Patout as chief marketing officer and Brett Buatti as vice president of operations.
David Denholm has returned to Kellogg Co. as chief executive officer of its Kashi Co. natural foods business. Denholm, who began in the Kashi CEO post earlier this month, formerly was president of U.S. morning foods at Kellogg. He reports to John Bryant, Kellogg chairman and CEO.
Takeda Pharmaceuticals USA Inc. and Orexigen Therapeutics Inc. have obtained Food and Drug Administration approval for Contrave extended-release tablets, a medication for chronic weight management.
Lannett Co. has received approval from the Food and Drug Administration for oxycodone hydrochloride oral solution (100 mg per 5 ml).
Rinovum Women’s Health has introduced The Stork conception aid in Canada at Rexall and London Drugs pharmacies.
Crest has launched Crest Sensi-Stop Strips, a new solution for tooth sensitivity that the oral care brand called "one of its most breakthrough product launches in a decade.
Singer and actress Demi Lovato has signed on with N.Y.C. New York Color as its first global brand ambassador. Demi Lovato The Coty Inc. value cosmetics brand said Friday that Lovato will be featured in global marketing and social media campaigns to support N.Y.C.
QS/1 has begun offering Veridikal Intelligence and Veridikal’s Reconciliation program to pharmacies using its automation solutions.
The Federal Trade Commission has filed a complaint in federal district court alleging that AbbVie Inc. and Teva Pharmaceuticals USA Inc. illegally blocked U.S. consumers’ access to generic versions of the testosterone gel AndroGel.
AstraZeneca has rolled out the Bydureon Pen (exenatide extended-release for injectable suspension, 2 mg), a treatment for type 2 diabetes, available to U.S. pharmacies.